- Description
-
Details
This comprehensive CE course is designed for advanced practice nurses and prescribing clinicians involved in the management of obesity in adult patients. It provides a clinically grounded and evidence-based overview of pharmacologic interventions used as part of a multi-modal approach to obesity treatment.
The course covers the pathophysiology of obesity and the mechanisms of action, indications, contraindications, and efficacy of FDA-approved anti-obesity medications. Emphasis is placed on individualized therapy selection, monitoring response to treatment, recognizing adverse effects, and managing drug interactions. Content also includes current clinical guidelines and the integration of pharmacotherapy with lifestyle and behavioral strategies.
Through real-world clinical scenarios, participants will enhance their ability to formulate and adjust treatment plans that align with patient-specific goals and comorbid conditions. The course reinforces best practices in therapeutic monitoring, patient education, and long-term obesity management.
Learning Objectives:
Upon successful completion of this course, participants will be able to:
- Describe the pathophysiology and classification of adult obesity.
- Identify appropriate candidates for pharmacologic treatment based on established clinical criteria.
- Compare and contrast FDA-approved anti-obesity medications, including their mechanisms, benefits, and risks.
- Develop individualized pharmacologic treatment plans in alignment with patient health status and goals.
- Monitor therapeutic outcomes and manage adverse effects and interactions associated with anti-obesity agents.
- Educate patients on medication adherence, lifestyle integration, and long-term weight management strategies.
Course Completion Requirements:
To complete this CE course and receive full credit, participants must:
- Register for the course.
- Review all course materials.
- Complete the post-test with a passing score of 70% or higher.
- Submit a completed course evaluation.
Note: Some courses may include additional assignments or clinical case reviews
Important Disclosures:
- Conflict of Interest: The course planners, authors, and presenters have no financial or commercial conflicts of interest related to this educational activity.
- Commercial Support: This course has not received sponsorship or financial support from commercial entities.
- Non-Endorsement: Approval of this course as a continuing education activity does not imply endorsement of any products, services, or companies mentioned within the content.
- Off-Label Product Use: Any discussion of off-label medication use is clearly identified and supported by available evidence.
Key Course Benefits:
- Provides 3 pharmacology credit hours.
- Offers an evidence-based overview of pharmacologic obesity treatment.
- Supports safe prescribing and long-term patient management.
- Designed for nurse practitioners, clinical nurse specialists, and other prescribing professionals.
- Delivered online for flexible, self-paced learning.
Approvals and Accreditation:
The CE Learning Network (CELN) is an accredited provider of continuing education for nurses, recognized by the Florida Board of Nursing and the District of Columbia Board of Nursing.
This course adheres to the standards established by the American Nurses Credentialing Center’s Commission on Accreditation.
Approved for the following nursing professionals:
- Florida Board of Nursing: LPNs, RNs, CNSs, ARNPs
- District of Columbia Board of Nursing: RNs, Nurse Anesthetists, CNSs, Midwives, ARNPs
For added convenience, CELN automatically reports earned CE hours to CEBroker.com on behalf of participants.